| Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. ME Medof, T Kinoshita, V Nussenzweig The Journal of experimental medicine 160 (5), 1558-1578, 1984 | 688 | 1984 |
| Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells MG Strainic, J Liu, D Huang, F An, PN Lalli, N Muqim, VS Shapiro, ... Immunity 28 (3), 425-435, 2008 | 672 | 2008 |
| Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. T Kinoshita, ME Medof, R Silber, V Nussenzweig The Journal of experimental medicine 162 (1), 75-92, 1985 | 465 | 1985 |
| Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. ME Medof, K Iida, C Mold, V Nussenzweig The Journal of experimental medicine 156 (6), 1739-1754, 1982 | 417 | 1982 |
| Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. ME Medof, EI Walter, JL Rutgers, DM Knowles, V Nussenzweig The Journal of experimental medicine 165 (3), 848-864, 1987 | 409 | 1987 |
| Membrane complement receptors specific for bound fragments of C3 GD Ross, ME Medof Advances in immunology 37, 217-267, 1985 | 409 | 1985 |
| Suppressor cell function in multiple sclerosis: correlation with clinical disease activity JP Antel, BGW Arnason, ME Medof Annals of Neurology: Official Journal of the American Neurological …, 1979 | 344 | 1979 |
| Decay-accelerating factor modulates induction of T cell immunity PS Heeger, PN Lalli, F Lin, A Valujskikh, J Liu, N Muqim, Y Xu, ME Medof The Journal of experimental medicine 201 (10), 1523-1530, 2005 | 335 | 2005 |
| Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells MG Strainic, EM Shevach, F An, F Lin, ME Medof Nature immunology 14 (2), 162-171, 2013 | 330 | 2013 |
| Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid ME Medof, EI Walter, WL Roberts, R Haas, TL Rosenberry Biochemistry 25 (22), 6740-6747, 1986 | 325 | 1986 |
| Locally produced C5a binds to T cell–expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis PN Lalli, MG Strainic, M Yang, F Lin, ME Medof, PS Heeger Blood, The Journal of the American Society of Hematology 112 (5), 1759-1766, 2008 | 319 | 2008 |
| Unraveling the mysteries of phospholipid scrambling PJ Sims, T Wiedmer Thrombosis and haemostasis 86 (07), 266-275, 2001 | 302 | 2001 |
| Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. ME Medof, DM Lublin, VM Holers, DJ Ayers, RR Getty, JF Leykam, ... Proceedings of the National Academy of Sciences 84 (7), 2007-2011, 1987 | 301 | 1987 |
| Cell‐surface engineering with GPI‐anchored proteins ME Medof, S Nagarajain, ML Tykocinski The FASEB Journal 10 (5), 574-586, 1996 | 265 | 1996 |
| Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from … M Takahashi, J Takeda, S Hirose, R Hyman, N Inoue, T Miyata, E Ueda, ... The Journal of experimental medicine 177 (2), 517-521, 1993 | 207 | 1993 |
| Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice MT Pritchard, MR McMullen, AB Stavitsky, JI Cohen, F Lin, ME Medof, ... Gastroenterology 132 (3), 1117-1126, 2007 | 199 | 2007 |
| Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. NK Cheung, EI Walter, WH Smith-Mensah, WD Ratnoff, ML Tykocinski, ... The Journal of clinical investigation 81 (4), 1122-1128, 1988 | 180 | 1988 |
| Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine. S Hirose, GM Prince, D Sevlever, L Ravi, TL Rosenberry, E Ueda, ... Journal of Biological Chemistry 267 (24), 16968-16974, 1992 | 168 | 1992 |
| Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum AD De Silva, J Park, N Matsuki, AK Stanic, RR Brutkiewicz, ME Medof, ... The Journal of Immunology 168 (2), 723-733, 2002 | 163 | 2002 |
| Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. EI Walter, WL Roberts, TL Rosenberry, WD Ratnoff, ME Medof Journal of immunology (Baltimore, Md.: 1950) 144 (3), 1030-1036, 1990 | 158 | 1990 |
